CARLSBAD, Calif., Feb. 22, 2023 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq:TYRA), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer, today announced that management will present at the following investor conferences:
Read more at prnewswire.comTyra Biosciences to Present at Upcoming Investor Conferences
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here